Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
Recent Posts
- Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
- Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
- FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
- AstraZeneca and Sun Pharma partner to help patients living with Hyperkalemia in India
- Sun Pharma launches ‘#SeeBeyondSugar’ campaign on World Diabetes Day: A nation-wide initiative to raise awareness about Diabetic Retinopathy
Recent Comments